| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| DHE16602A |
Research Grade Olinvacimab |
100 ug |
$430.00
|
 |
BUY
|
| DHE16602B |
Research Grade Olinvacimab |
1.0 mg |
$1,560.00
|
|
BUY
|
| DHJ04002B |
Research Grade Omburtamab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ04002A |
Research Grade Omburtamab |
100 ug |
$380.00
|
|
BUY
|
| DHL04002B |
Research Grade Omburtamab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD17405A |
Research Grade Oportuzumab |
100 ug |
$490.00
|
|
BUY
|
| DHD17405B |
Research Grade Oportuzumab |
1.0 mg |
$1,790.00
|
|
BUY
|
| DHH02233B |
Research Grade Peresolimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHH02233A |
Research Grade Peresolimab |
100 µg |
$420.00
|
|
BUY
|
| DHH02216A |
Research Grade Pidilizumab |
100 ug |
$380.00
|
|
BUY
|
| DHH02216B |
Research Grade Pidilizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ48301B |
Research Grade Ponsegromab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHJ48301A |
Research Grade Ponsegromab |
100 ug |
$420.00
|
|
BUY
|
| DHH02217A |
Research Grade Prolgolimab |
100 ug |
$430.00
|
|
BUY
|
| DHH02217B |
Research Grade Prolgolimab |
1.0 mg |
$1,560.00
|
|
BUY
|
| DHH02218A |
Research Grade Retifanlimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02218B |
Research Grade Retifanlimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD18001A |
Research Grade Rolinsatamab |
100 ug |
$420.00
|
|
BUY
|
| DHD18001B |
Research Grade Rolinsatamab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHH02234A |
Research Grade Rosnilimab |
100 µg |
$420.00
|
|
BUY
|
| DHH02234B |
Research Grade Rosnilimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHG01304A |
Research Grade Rosopatamab |
100 ug |
$420.00
|
|
BUY
|
| DHG01304B |
Research Grade Rosopatamab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHC09612A |
Research Grade Runimotamab |
100 ug |
$615.00
|
|
BUY
|
| DHC09612B |
Research Grade Runimotamab |
1.0 mg |
$2,235.00
|
|
BUY
|
| DHH02219B |
Research Grade Sasanlimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02219A |
Research Grade Sasanlimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02213B |
Research Grade Serplulimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02213A |
Research Grade Serplulimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02207B |
Research Grade Sintilimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02207A |
Research Grade Sintilimab |
100 ug |
$380.00
|
|
BUY
|
| DHD17407A |
Research Grade Solitomab |
100 ug |
$560.00
|
|
BUY
|
| DHD17407B |
Research Grade Solitomab |
1.0 mg |
$2,030.00
|
|
BUY
|
| DHC33102B |
Research Grade Sotatercept |
1.0 mg |
$1,970.00
|
|
BUY
|
| DHC33102A |
Research Grade Sotatercept |
100 ug |
$540.00
|
|
BUY
|
| DHH02214B |
Research Grade Spartalizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02214A |
Research Grade Spartalizumab |
100 ug |
$380.00
|
|
BUY
|
| DHH72406A |
Research Grade Tamgiblimab |
100 ug |
$420.00
|
|
BUY
|
| DHH72406B |
Research Grade Tamgiblimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHE16604B |
Research Grade Tanibirumab |
1.0 mg |
$1,560.00
|
|
BUY
|
| DHE16604A |
Research Grade Tanibirumab |
100 ug |
$430.00
|
|
BUY
|
| DHC27706A |
Research Grade Tebentafusp |
100 ug |
$540.00
|
|
BUY
|
| DHF92402A |
Research Grade Teclistamab |
100 ug |
$615.00
|
|
BUY
|
| DHF92402B |
Research Grade Teclistamab |
1.0 mg |
$2,235.00
|
|
BUY
|
| DHC34203A |
Research Grade Telisotuzumab |
100 ug |
$420.00
|
|
BUY
|
| DHC34203B |
Research Grade Telisotuzumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHC34299B |
Research Grade Telisotuzumab vedotin (ADC) |
5.0 mg |
$6,325.00
|
|
BUY
|
| DHC34299A |
Research Grade Telisotuzumab vedotin (ADC) |
1.0 mg |
$2,915.00
|
|
BUY
|
| DHD72101A |
Research Grade Tesnatilimab |
100 ug |
$380.00
|
|
BUY
|
| DHD72101B |
Research Grade Tesnatilimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC09605A |
Research Grade Timigutuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHC09605B |
Research Grade Timigutuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02206B |
Research Grade Tislelizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02206A |
Research Grade Tislelizumab |
100 ug |
$380.00
|
|
BUY
|
| DHA95501B |
Research Grade Tomaralimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHA95501A |
Research Grade Tomaralimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02208A |
Research Grade Toripalimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02208B |
Research Grade Toripalimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC09698A |
Research Grade Trastuzumab deruxtecan (ADC) |
1.0 mg |
$2,915.00
|
|
BUY
|
| DHC09698B |
Research Grade Trastuzumab deruxtecan (ADC) |
5.0 mg |
$7,240.00
|
|
BUY
|
| DHF39901A |
Research Grade Ulocuplumab (BMS-936564 / MDX-1338) |
100 ug |
$420.00
|
|
BUY
|
| DHF39901B |
Research Grade Ulocuplumab (BMS-936564 / MDX-1338) |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHA30101B |
Research Grade Vesencumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHA30101A |
Research Grade Vesencumab |
100 ug |
$380.00
|
|
BUY
|
| DHJ45501A |
Research Grade Vixarelimab |
100 ug |
$420.00
|
|
BUY
|
| DHJ45501B |
Research Grade Vixarelimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD52901B |
Research Grade Vofatamab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD52901A |
Research Grade Vofatamab |
100 ug |
$420.00
|
|
BUY
|
| DHJ92101B |
Research Grade Vopratelimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ92101A |
Research Grade Vopratelimab |
100 ug |
$380.00
|
|
BUY
|
| DHE16605B |
Research Grade Vulinacimab |
1.0 ug |
$1,380.00
|
|
BUY
|
| DHE16605A |
Research Grade Vulinacimab |
100 ug |
$380.00
|
|
BUY
|
| DHC09607B |
Research Grade Zanidatamab |
1.0 mg |
$1,790.00
|
|
BUY
|
| DHC09607A |
Research Grade Zanidatamab |
100 ug |
$490.00
|
|
BUY
|
| DHC09609A |
Research Grade Zenocutuzumab |
100 ug |
$560.00
|
|
BUY
|
| DHC09609B |
Research Grade Zenocutuzumab |
1.0 mg |
$2,030.00
|
|
BUY
|
| DHF90701B |
Research Grade Zilovertamab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHF90701A |
Research Grade Zilovertamab |
100 ug |
$420.00
|
|
BUY
|
